(Q40928902)

24 September 2017

1 reference

title

Human leukocyte interferon alpha: structure, pharmacology, and therapeutic applications (English)

1 reference

24 September 2017

Viscomi GC

1

1 reference

24 September 2017

Grimaldi M

series ordinal

2

1 reference

24 September 2017

Palazzini E

series ordinal

3

1 reference

24 September 2017

Silvestri S

series ordinal

4

1 reference

24 September 2017

publication date

1 September 1995

1 reference

Medicinal Research Reviews

24 September 2017

published in

1 reference

24 September 2017

volume

15

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

445-478

1 reference

Interferon—A Major Regulator of Natural Killer Cell-Mediated Cytotoxicity

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Natural human interferon-alpha 2 is O-glycosylated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Binding of human alpha-interferons to natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Antiproliferative activity of human interferons against ovarian cancer cells grown in human tumor stem cell assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Different interactions of interferon-alpha subtypes at the surface of epithelial and lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Analysis of interferon-alpha 2 sequences in human genomic DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Characterization of three species of Escherichia coli-derived human leukocyte interferon A separated by reverse-phase high-performance liquid chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Recombinant human interferon-alpha 2a increases hormone receptor level of a human breast carcinoma xenograft in nude mice and enhances the anti-proliferative activity of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

The role of three domains in the biological activity of human interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Antibodies developing against a single recombinant interferon protein may neutralize many other interferon-alpha subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Production of two human 2',5'-oligoadenylate synthetase enzymes in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Combination Therapy for Dendritic Keratitis With Acyclovir and -Interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Human leukocyte interferon in the treatment and prophylaxis of acute hemorrhagic conjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Clinical results of leukocyte interferon-induced tumor regression in resistant human metastatic cancer resistant to chemotherapy and/or radiotherapy-pulse therapy schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Disease stabilization by leukocyte alpha interferon and survival of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610150504

21 January 2018

Identifiers

DOI

10.1002/MED.2610150504

1 reference

24 September 2017

1 reference